- Home
- KPRX vs SPI Comparison
KPRX vs SPI Comparison
Compare KPRX & SPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- SPI
- Stock Information
- Founded
- KPRX 1998
- SPI N/A
- Country
- KPRX United States
- SPI United States
- Employees
- KPRX N/A
- SPI N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SPI Semiconductors
- Sector
- KPRX Health Care
- SPI Technology
- Exchange
- KPRX Nasdaq
- SPI Nasdaq
- Market Cap
- KPRX 10.0M
- SPI 10.2M
- IPO Year
- KPRX N/A
- SPI N/A
- Fundamental
- Price
- KPRX $3.26
- SPI $0.45
- Analyst Decision
- KPRX Strong Buy
- SPI Hold
- Analyst Count
- KPRX 1
- SPI 1
- Target Price
- KPRX $10.00
- SPI N/A
- AVG Volume (30 Days)
- KPRX 34.9K
- SPI 3.5M
- Earning Date
- KPRX 11-08-2024
- SPI 12-31-2024
- Dividend Yield
- KPRX N/A
- SPI N/A
- EPS Growth
- KPRX N/A
- SPI N/A
- EPS
- KPRX 1.69
- SPI N/A
- Revenue
- KPRX $16,020,000.00
- SPI $209,528,000.00
- Revenue This Year
- KPRX N/A
- SPI $19.94
- Revenue Next Year
- KPRX N/A
- SPI $24.15
- P/E Ratio
- KPRX $2.04
- SPI N/A
- Revenue Growth
- KPRX N/A
- SPI 22.29
- 52 Week Low
- KPRX $3.00
- SPI $0.27
- 52 Week High
- KPRX $8.98
- SPI $0.90
- Technical
- Relative Strength Index (RSI)
- KPRX 43.44
- SPI 68.17
- Support Level
- KPRX $3.30
- SPI $0.31
- Resistance Level
- KPRX $4.04
- SPI $0.48
- Average True Range (ATR)
- KPRX 0.28
- SPI 0.04
- MACD
- KPRX -0.01
- SPI 0.02
- Stochastic Oscillator
- KPRX 7.14
- SPI 86.02
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About SPI SPI Energy Co. Ltd.
SPI Energy Co Ltd offers photovoltaic solutions for business, residential, government, and utility customers and investors. The company provides a range of engineering, procurement, and construction services to third-party project developers. It is also engaged in the development, manufacture, and marketing of various PV modules. It procures PV modules and other equipment for project construction from independent suppliers and contract work to third-party EPC contractors in areas such as logistics, installation, construction, and supervision. The company's geographical segments are the United Kingdom, Australia, United States, Greece, Japan, and Italy, of which the majority of its revenue comes from Australia.